Evidence map›Paper›PMID 34160529›Full record

ArticleNanoscale2021

Just add water: hydratable, morphologically diverse nanocarrier powders for targeted delivery.

Sharan Bobbala, Michael P Vincent, Evan A Scott

Abstract read
In one paragraph

Article in Nanoscale, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sharan BobbalaDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA. evan.scott@northwestern.edu.ORCID http://orcid.org/0000-0002-0740-330X
Michael P VincentDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA. evan.scott@northwestern.edu.
Evan A ScottDepartment of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA. evan.scott@northwestern.edu and Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois, USA and Simpson Querrey Institute, Northwestern University, Chicago, Illinois, USA and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.ORCID http://orcid.org/0000-0002-8945-2892

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccinationR01AI145345 · NIAID · NORTHWESTERN UNIVERSITY · PI SCOTT, EVAN ALEXANDER, WANG, CHYUNG-RU · 2019 to 2022
$2.9M
Development of combination immunotherapies for atherosclerotic inflammationDP2HL132390 · NHLBI · NORTHWESTERN UNIVERSITY · PI SCOTT, EVAN ALEXANDER · 2015 to 2015
$2.3M
Visual Sciences T32T32EY025202 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Gregory William Schwartz · 2015 to 2026
$1.4M
Leveraging immunostimulatory pathways that enhance BCG vaccination for the rational design of synthetic neonatal vaccine formulationsR21AI137932 · NIAID · NORTHWESTERN UNIVERSITY · PI DOWLING, DAVID JAMES, SCOTT, EVAN ALEXANDER · 2019 to 2020
$468k
NCI NIH HHS P30 CA060553NEI NIH HHS T32 EY025202NHLBI NIH HHS DP2 HL132390NIAID NIH HHS R01 AI145345NIAID NIH HHS R21 AI137932
6 · The paper itself

Abstract

Two major obstacles that limit the widespread usage of polymeric nanocarriers include the complexity of formulation methods and their stability during storage. To address both of these issues, here we present morphologically complex nanocarriers in a hydratable powder form, which bypasses the need for expensive, harsh, and/or time-consuming nanocarrier fabrication techniques. The powders are composed of carbohydrates and self-assembling polymer amphiphiles having a low glass transition temperature. Hydration requires less than one minute and only involves the addition of aqueous media (water or saline) to rapidly obtain self-assembled micelles, worm-like micelles (i.e. filomicelles), or polymersomes from poly(ethylene glycol)-b-poly(propylene sulfide) (PEG-b-PPS) polymers. The formulated powders are highly stable, achieving hydration into monodisperse nanocarriers following >6 months of storage. Diverse drug cargoes were efficiently encapsulated during hydration, including hydrophobic small molecules for micellar morphologies, as well as individual and concurrent loading of both hydrophobic and hydrophilic molecules for vesicular morphologies. Hydrated polymersomes are shown to load hydrophilic biological macromolecules, and encapsulated enzymes retain bioactivity. Furthermore, we demonstrate that inclusion of lipid-anchored ligands in powder form permits the surface-display of targeting ligands and enhances target cell uptake, thereby extending this technology to targeted drug delivery applications. Our powder-based formulation strategy was extendable to commercially available polymer amphiphiles, including PEG-b-polystyrene and PEG-b-polycaprolactone. The formulated nanotechnologies described herein are highly modular, require minimal preparation, and remain stable in ambient long-term storage (bypassing cold chain requirements), which will enable their use in medicine (human and veterinary), research, and commercial applications from cosmetics to agriculture.

Indexed as

Polyethylene GlycolsWaterDrug CarriersDrug Delivery SystemsHumansHydrophobic and Hydrophilic InteractionsMicellesPolymersPowdersDrug CarriersMicellesPolyethylene GlycolsPolymersPowdersWater

Identifiers

PMID34160529
PMCPMC8343964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.